Munafa Stock Market Course + Intraday & FNO calls 
Protagonist Therapeutics (PTGX) Technical (Analysis) Reports Protagonist Therapeutics ["Technical Analysis"] Reports -USA Stock Exchange MunafaSutra.com
Complete & easy to understand technical analysis of Protagonist Therapeutics (PTGX)
Technical Analysis Report for USA stock PTGX Protagonist Therapeutics. Dated: 16 Dec 2025 Updated Daily. Stock trades under Health Care Deals in Major Pharmaceuticals in USA stock exchange
If you are looking for Tomorrow's Movement Predictions for USA stock PTGX Protagonist Therapeutics then click here. or read Experts views on Protagonist Therapeutics or Forecast & share price targets of Protagonist Therapeutics
Protagonist Therapeutics Opened at 93.93 and Closed at: 91.54, which is -3.55% of previous session's close. It moved within a range of 90.18 and 94.54
The session was a Bearish session with an average volume of 881100, which is -8.94% of previous session's volumes.
- Even though the stock has fallen, but its short term trend is positive and in an uptrend.
- Even though the stock has fallen, but its mid term trend is positive and in an uptrend.
- Even though the stock has fallen, but its long term trend is positive and in an uptrend.
Support for tomorrow is 88.68 and resistance for tomorrow is 93.04
These support and resistance points are valid for the first 5-15 minutes charts
Above are simple pivot point calculations. For a list of much stronger support and resistance levels click here. These are way more stronger support and resistance levels, and mark trend reversals and are Support & Resistance levels recommended by experts.
Support for tomorrow's hourly charts is 89.63, 87.73 resistance for tomorrow's hourly charts is 93.99, 96.45
10 Day SMA for Protagonist Therapeutics (PTGX) is 90.72 and stock is trading above these levels. This is a good sign for its short term trend
20 Day SMA for Protagonist Therapeutics (PTGX) is 88.71 and the stock is trading above these levels. This is a good sign for its mid term trend
50 Day SMA for Protagonist Therapeutics (PTGX) is 82.11 and the stock is trading above these levels. This is a good sign for its mid to long term trend
100 Day SMA is 70.44 and the stock is trading above these levels. This is a good sign for its long term trend
200 Day SMA Protagonist Therapeutics is 59.78 and stock is trading above these levels. This is a good sign for its long term trend
20 DMA of Protagonist Therapeutics is at 88.71 and 200 DMA is at 59.78, while 50 DMA and 100 DMA are at 82.11 and 70.44 respectively
Protagonist Therapeutics (PTGX) moving average of 20 SMA is at 88.71 and 20 EMA is at 88.76
| Date | Closing Price | 20 SMA | 20 EMA |
| 16 Tue Dec | 91.54 | 88.71 | 88.76 |
| 15 Mon Dec | 94.79 | 88.37 | 88.47 |
| 12 Fri Dec | 95.35 | 87.86 | 87.81 |
| 11 Thu Dec | 92.25 | 87.26 | 87.02 |
| 10 Wed Dec | 91.38 | 86.89 | 86.47 |
| 09 Tue Dec | 88.56 | 86.59 | 85.95 |
Protagonist Therapeutics (PTGX) moving average of 50 SMA is at 82.11 and 50 EMA is at 82.06
| Date | Closing Price | 50 SMA | 50 EMA |
| 16 Tue Dec | 91.54 | 82.11 | 82.06 |
| 15 Mon Dec | 94.79 | 81.56 | 81.67 |
| 12 Fri Dec | 95.35 | 80.96 | 81.13 |
| 11 Thu Dec | 92.25 | 80.34 | 80.55 |
| 10 Wed Dec | 91.38 | 79.78 | 80.07 |
| 09 Tue Dec | 88.56 | 79.28 | 79.61 |
Protagonist Therapeutics (PTGX) moving average of 100 SMA is at 70.44 and 100 EMA is at 73.59
| Date | Closing Price | 100 SMA | 100 EMA |
| 16 Tue Dec | 91.54 | 70.44 | 73.59 |
| 15 Mon Dec | 94.79 | 70.07 | 73.23 |
| 12 Fri Dec | 95.35 | 69.66 | 72.79 |
| 11 Thu Dec | 92.25 | 69.25 | 72.33 |
| 10 Wed Dec | 91.38 | 68.88 | 71.93 |
| 09 Tue Dec | 88.56 | 68.52 | 71.54 |
Protagonist Therapeutics (PTGX) moving average of 200 SMA is at 59.78 and 200 EMA is at 63.79
| Date | Closing Price | 200 SMA | 200 EMA |
| 16 Tue Dec | 91.54 | 59.78 | 63.79 |
| 15 Mon Dec | 94.79 | 59.51 | 63.51 |
| 12 Fri Dec | 95.35 | 59.22 | 63.19 |
| 11 Thu Dec | 92.25 | 58.93 | 62.87 |
| 10 Wed Dec | 91.38 | 58.64 | 62.57 |
| 09 Tue Dec | 88.56 | 58.36 | 62.28 |
Protagonist Therapeutics has performed better than Unitedhealth Group in short term. Holding Protagonist Therapeutics could be a better choice for now!
Protagonist Therapeutics has performed better than Novo Nordisk in short term. Holding Protagonist Therapeutics could be a better choice for now!
Protagonist Therapeutics has performed better than Medtronic Plc in short term. Holding Protagonist Therapeutics could be a better choice for now!
Protagonist Therapeutics has performed better than Concord Medical in short term. Holding Protagonist Therapeutics could be a better choice for now!
Protagonist Therapeutics has performed better than Zynex Inc in short term. Holding Protagonist Therapeutics could be a better choice for now!
Protagonist Therapeutics has performed better than Nektar Therapeutics in short term. Holding Protagonist Therapeutics could be a better choice for now!
Moderna Inc has performed better than Protagonist Therapeutics in short term. You could have earned much better returns by investing in Moderna Inc, about 11.47% more returns!
Luminex Corporation has performed better than Protagonist Therapeutics in short term. You could have earned much better returns by investing in Luminex Corporation, about 24.34% more returns!
Kalvista Pharmaceuticals has performed better than Protagonist Therapeutics in short term. You could have earned much better returns by investing in Kalvista Pharmaceuticals, about 2.95% more returns!
Protagonist Therapeutics has performed better than Jazz Pharmaceuticals in short term. Holding Protagonist Therapeutics could be a better choice for now!
Inmune Bio has performed better than Protagonist Therapeutics in short term. You could have earned much better returns by investing in Inmune Bio, about 17.53% more returns!
Protagonist Therapeutics has performed better than Gilead Sciences in short term. Holding Protagonist Therapeutics could be a better choice for now!
Protagonist Therapeutics has performed better than Fulgent Genetics in short term. Holding Protagonist Therapeutics could be a better choice for now!
Protagonist Therapeutics has performed better than Ensign Group in short term. Holding Protagonist Therapeutics could be a better choice for now!
Protagonist Therapeutics has performed better than Cytokinetics Incorporated in short term. Holding Protagonist Therapeutics could be a better choice for now!
Aclaris Therapeutics has performed better than Protagonist Therapeutics in short term. You could have earned much better returns by investing in Aclaris Therapeutics, about 20.45% more returns!
Protagonist Therapeutics Technical analysis of indicators
Price action analysis of Protagonist Therapeutics (PTGX) based on a short term time period is definitely positive! This means that there is a strong uptrend in the stock for the given time period. Buyers are extremely bullish on the stock.
ADX buy sell signal for Protagonist Therapeutics stock for short term is BUY. Signal strength is Weak and stock is losing momentum.
MACD generated a BUY signal for Protagonist Therapeutics in short term and the buy signal is strong.
Protagonist Therapeutics Stock is trading near its recent HIGHS, which reflects strong buying momentum in short term! Bulls are getting tired and bears are picking up momentum.
Ichimoku cloud is of green color and prices are above the green cloud Prices appear to be coming down
CCI has generated a SELL signal for Protagonist Therapeutics in short term but SELL signal is weak.
RSI is generating a BUY signal in short term but buying is losing momentum.
MRSI is in negative zone. This is the SELL zone
Stock of Protagonist Therapeutics is picking up buying momentum according to indicator.
Volume based indicators are showing selling momentum.
Volume Weighted Averaged Price (VWAP) for short term is 90.85 and Protagonist Therapeutics PTGX stock is trading above this level. This is a good sign for the stock and it could move higher. VWAP is rising upwards.
People seem to be coming out and selling the Protagonist Therapeutics PTGX stock. Volume based technical analysis of Protagonist Therapeutics PTGX stock is negative.
Protagonist Therapeutics Stock is giving positive returns over a short term period. Returns for a longer term period have been positive
Force Index is moving in a negative zone, which indicates selling momentum for short term... Selling momentum is getting weaker.
Tomorrow's Predictions
You should also read Tomorrow's Movement Predictions for USA stock PTGX Protagonist Therapeutics These predictions are based on various factors, are easy to understand, and upto 75% accurate!
And PTGX Experts View which covers a lot of information including buying and selling signals
PTGX future forecast & share price targets
You can also take a look at the Charts and indicator analysis here Announcements & NEWS by Protagonist Therapeutics or View Candle Stick Charts here
Quick Charts: Renko Point & Figure Just IntraDay All Indicators Weekly Monthly All in One Eagle View MACD & ADX
Videos related to: Protagonist Therapeutics (PTGX) Technical (Analysis) Reports Protagonist Therapeutics ["Technical Analysis"] Reports -USA Stock Exchange MunafaSutra.com
Hindi Basics How To Trade In FnO Futures Options Stock Market
Hindi Video The Truth Of Stock Markets That Everyone Is Hiding From You
- USA Screeners
- USA Daily Screener
- USA Weekly Screener
- USA Monthly Screener
- Support & Resistance
- USA Shares Near Support
- USA Shares Near Resistance
